RAPT Therapeutics Highlights Early Results for RPT193 at Society for Investigative Dermatology Meeting

Encouraging results from preclinical and healthy volunteer studies for RPT193 were presented at the Society for Investigative Dermatology (SID) Meeting. RPT193 is an oral therapy in development for the treatment of atopic dermatitis and other allergic inflammatory diseases, BioSpace reports.